Current chemotherapeutic regimens achieve CR in a large percentage of patients with AML. However, relapse after CR remains a significant problem. The presence of leukemic cells at levels too low to be ...
No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2004 ASCO Annual Meeting. This abstract does not include a full text component.
A total of 125 patients with de novo B-ALL were enrolled in this study from October 2008 to August 2011 in our center. The diagnostic and immunological classification of ALL was established according ...
Flow cytometry is a powerful tool to analyze and characterize cells based on their protein expression, most often those expressed on the cell surface. Multicolor flow cytometry uses multiple ...
Cytokines play a critical role as mediators of immune responses and are generated by a variety of cells. Methods that can be used to measure cytokine levels in a sample and differentiate between ...
Flow cytometry’s next chapter is here. Opening the door to deeper immunological insights, Cytek Biosciences Inc., a leading provider of flow cytometry instrumentation, today announced that it has ...
A recent study described the use of multiparameter flow cytometry to detect minimal residual disease, with an 8-color flow cytometric method with a 105 sensitivity, using monoclonal antibodies in ...
Flow cytometry is a widely used analytical technique that distinguishes between cell populations depending on the presence or absence of chosen markers. However, the number of markers that can be ...
SAN DIEGO--(BUSINESS WIRE)--#invivoscribe--Today Invivoscribe, a global leader in precision diagnostics, announced the launch of a new 12-color multiparametric flow cytometry service in Shanghai, ...
[Fremont, CA, USA] – Flow cytometry’s next chapter is here. Opening the door to deeper immunological insights, Cytek Biosciences Inc., a leading provider of flow cytometry instrumentation, announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results